Pancreatic cancer is one of the most aggressive human tumors and the incidence has increased over the last 6 years. In the majority of cases the disease is already in an advanced stage at the time of diagnosis where surgery, the only curative treatment, is no longer an option and explains the still abysmal overall survival. The role of radiation therapy as treatment option for patients with pancreatic cancer is controversially discussed although radiation oncology has emerged as a central pillar in the combined oncological treatment. The present manuscript gives an overview of advanced radiotherapeutic strategies in the context of chemotherapy and surgery according to the current American Society of Clinical Oncology (ASCO) guidelines in co...
A small number of patients exist with carcinoma of the pancreas with an inoperable but not metastasi...
The number of deaths from pancreatic cancer in Japan exceeds 26,000 per year, and the number is incr...
Pancreatic cancer (PC) has the worst prognosis among all cancers, with a 5-year survival rate of les...
International audienceAt diagnosis, about 15% of patients with pancreatic cancer present with a rese...
Abstract Pancreatic ductal carcinoma is one of the most lethal malignancies, but in recent years a n...
Pancreatic ductal carcinoma is one of the most lethal malignancies, but in recent years a number of ...
[[abstract]]Despite combination chemotherapy demonstrating a positive effect on survival, the clinic...
Pancreatic cancer is a formidable malignancy with poor outcomes. The majority of patients are unable...
Pancreatic cancer is a formidable malignancy with poor outcomes. The majority of patients are unable...
AbstractPancreatic carcinoma is a malignancy with a poor prognosis and the 4th. most common cause of...
We aimed to demonstrate a single institution experience of treatment of pancreatic ductal carcinoma ...
Pancreatic cancer is a devastating disease with few effective treatment modalities. Stereotactic bod...
This article summarizes the expert discussion on the management of pancreatic cancer, which took pla...
Summary. The aim of the study was to evaluate the impact of different treatment methods on survival ...
This article summarizes the expert discussion on the management of pancreatic cancer, which took pla...
A small number of patients exist with carcinoma of the pancreas with an inoperable but not metastasi...
The number of deaths from pancreatic cancer in Japan exceeds 26,000 per year, and the number is incr...
Pancreatic cancer (PC) has the worst prognosis among all cancers, with a 5-year survival rate of les...
International audienceAt diagnosis, about 15% of patients with pancreatic cancer present with a rese...
Abstract Pancreatic ductal carcinoma is one of the most lethal malignancies, but in recent years a n...
Pancreatic ductal carcinoma is one of the most lethal malignancies, but in recent years a number of ...
[[abstract]]Despite combination chemotherapy demonstrating a positive effect on survival, the clinic...
Pancreatic cancer is a formidable malignancy with poor outcomes. The majority of patients are unable...
Pancreatic cancer is a formidable malignancy with poor outcomes. The majority of patients are unable...
AbstractPancreatic carcinoma is a malignancy with a poor prognosis and the 4th. most common cause of...
We aimed to demonstrate a single institution experience of treatment of pancreatic ductal carcinoma ...
Pancreatic cancer is a devastating disease with few effective treatment modalities. Stereotactic bod...
This article summarizes the expert discussion on the management of pancreatic cancer, which took pla...
Summary. The aim of the study was to evaluate the impact of different treatment methods on survival ...
This article summarizes the expert discussion on the management of pancreatic cancer, which took pla...
A small number of patients exist with carcinoma of the pancreas with an inoperable but not metastasi...
The number of deaths from pancreatic cancer in Japan exceeds 26,000 per year, and the number is incr...
Pancreatic cancer (PC) has the worst prognosis among all cancers, with a 5-year survival rate of les...